ImmuPharma plc (AIM:IMM)
London · Delayed Price · Currency is GBP · Price in GBX 4.855
+0.140 (2.97%)
Apr 15, 2026, 4:35 PM GMT
ImmuPharma Market Cap
ImmuPharma has a market cap or net worth of 30.29 million as of April 15, 2026. Its market cap has increased by 98.74% in one year.
Market Cap
30.29M
Enterprise Value
29.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.86
Market Cap Chart
Since February 22, 2006, ImmuPharma's market cap has decreased from 36.11M to 30.29M, a decrease of -16.12%. That is a compound annual growth rate of -0.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 29.42M | -5.62% |
| Dec 31, 2025 | 31.17M | 521.13% |
| Dec 31, 2024 | 5.02M | -27.71% |
| Dec 29, 2023 | 6.94M | 13.16% |
| Dec 30, 2022 | 6.13M | -62.85% |
| Dec 31, 2021 | 16.51M | -50.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 4basebio | 78.16M |
| hVIVO | 59.19M |
| Ondine Biomedical | 58.45M |
| Hemogenyx Pharmaceuticals | 55.58M |
| Faron Pharmaceuticals Oy | 51.41M |
| Poolbeg Pharma | 31.73M |
| Sareum Holdings | 25.54M |
| SkinBioTherapeutics | 25.27M |